Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuyanle capsule for bacterial vaginosis (phase III)
CTR20130904Phase 3Active
- Sponsor
- Fangsheng Pharmaceutical
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fuyanle in bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), leukorrhea, sponsored by Fangsheng Pharmaceutical. Started Oct 2014; status: active.
02
Drugs
Fuyanle
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)leukorrhea
Beyond the preview
Go deeper on CTR20130904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130904.